4D Intracardiac Echocardiography for Atrial Fibrillation

Evaluation of 4D Intracardiac Echocardiography (ICE) During Structural Heart and Electrophysiology Procedures

Recruiting N/A Interventional Study
Atrial Fibrillation
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
20 (estimated)
Sponsor
The Cleveland Clinic · Other
Who this trial is looking for

This trial is looking for adults who are scheduled for a specific heart procedure. Participants will help test a new imaging technology during the procedure.

Are You a Good Fit for This Trial?
Rules you out SepsisCerebral ischemic eventDeep vein thrombosis

You may be able to join if

  • I am over 18 years old
  • I am scheduled for a LAAO transcatheter procedure
  • I can give informed consent
  • I will have ablation before the LAAO procedure if applicable

You may not be able to join if

  • I am currently in another clinical study
  • I have a bleeding disorder
  • I have a vascular problem that makes catheterization impossible
  • I have a blood clot in my heart
  • I had a heart attack in the past two months
  • I have severe heart failure or angina
  • I have an active infection
  • I have a weakened immune system

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to evaluate the imaging performance and procedural safety of a prototype 4D ICE catheter during real-time intracardiac imaging and to optimize device imaging parameters, compared with current standard imaging modalities. TEE is the current standard of care and will serve as the primary imaging modality for clinical guidance during the EP and Structural Heart Disease (…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Be aged above 18 for adult participants 2. Be scheduled for a LAAO transcatheter procedure with or without concurrent procedures. 3. Be able and willing to give informed consent 4. (For concomitant cases only) Ablation will occur prior to LAAO implantation Exclusion Criteria…
Contacts

Walid Saliba, MD

216-444-6810

salibaw@ccf.org

CONTACT